Paulson Wealth Management Inc. Abb Vie Inc. Transaction History

Paulson Wealth Management Inc.

$371 Million
Q3 2024

A detailed history of Paulson Wealth Management Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Paulson Wealth Management Inc. holds 6,394 shares of ABBV stock, worth $1.13 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

6,394

Previous 7,094 9.87%

Holding current value

$1.13 Million

Previous $1.22 Million 3.78%

% of portfolio

0.34%

Previous 0.36%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$163.84 - $199.33 $114,688 - $139,531	-700 Reduced 9.87%	6,394 $1.26 Million
Q2 2024 Jul 25, 2024	SELL	$154.79 - $180.76 $35,911 - $41,936	-232 Reduced 3.17%	7,094 $1.22 Million
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $11,507 - $13,111	-72 Reduced 0.97%	7,326 $1.33 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $152,460 - $171,706	-1,108 Reduced 13.03%	7,398 $1.15 Million
Q3 2023 Nov 01, 2023	BUY	$133.59 - $154.65 $126,108 - $145,989	944 Added 12.48%	8,506 $1.27 Million
Q2 2023 Aug 01, 2023	BUY	$132.51 - $164.9 $137,280 - $170,836	1,036 Added 15.87%	7,562 $1.02 Million
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $15,473 - $17,819	107 Added 1.67%	6,526 $1.04 Million
Q4 2022 Jan 26, 2023	SELL	$138.31 - $165.87 $5,394 - $6,468	-39 Reduced 0.6%	6,419 $0
Q3 2022 Nov 02, 2022	BUY	$134.21 - $153.93 $866,728 - $994,079	6,458 New	6,458 $867,000
Q4 2021 Jan 28, 2022	SELL	$107.43 - $135.93 $727,086 - $919,974	-6,768 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$106.4 - $120.78 $1,489 - $1,690	14 Added 0.21%	6,768 $730,000
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $20,305 - $22,621	193 Added 2.94%	6,754 $761,000
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $14,015 - $15,428	137 Added 2.13%	6,561 $701,000
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $35,737 - $48,249	444 Added 7.42%	6,424 $688,000
Q3 2020 Oct 14, 2020	BUY	$85.91 - $100.83 $37,542 - $44,062	437 Added 7.88%	5,980 $524,000
Q2 2020 Jul 17, 2020	BUY	$73.37 - $98.18 $14,967 - $20,028	204 Added 3.82%	5,543 $544,000
Q1 2020 Apr 29, 2020	BUY	$64.5 - $97.79 $19,414 - $29,434	301 Added 5.97%	5,339 $437,000
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $9,016 - $11,281	125 Added 2.54%	5,038 $443,000
Q3 2019 Oct 30, 2019	SELL	$62.98 - $75.72 $10,895 - $13,099	-173 Reduced 3.4%	4,913 $372,000
Q2 2019 Jul 30, 2019	BUY	$65.7 - $83.98 $6,372 - $8,146	97 Added 1.94%	5,086 $344,000
Q1 2019 Apr 24, 2019	SELL	$77.14 - $90.79 $6,556 - $7,717	-85 Reduced 1.68%	4,989 $402,000
Q4 2018 Jan 23, 2019	SELL	$77.85 - $96.01 $214,087 - $264,027	-2,750 Reduced 35.15%	5,074 $450,000
Q3 2018 Oct 26, 2018	SELL	$88.91 - $98.84 $30,140 - $33,506	-339 Reduced 4.15%	7,824 $649,000
Q2 2018 Aug 01, 2018	SELL	$89.78 - $106.23 $11,581 - $13,703	-129 Reduced 1.56%	8,163 $756,000
Q1 2018 May 02, 2018	SELL	$92.01 - $123.21 $86,213 - $115,447	-937 Reduced 10.15%	8,292 $785,000
Q4 2017 Mar 01, 2018	BUY	$89.56 - $98.21 $826,549 - $906,380	9,229	9,229 $893,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paulson Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Paulson Wealth Management Inc. with notifications on news.

Account

Paulson Wealth Management Inc. Abb Vie Inc. Transaction History